USPTO serial 78844073
IBIS BIOSCIENCES
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PILARO, MARK F
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IBIS BIOSCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary L. Winburn
Mary L. Winburn Abbott Laboratories100 Abbott Park RoadD377/AP6AAbbott Park, IL 60064-6008Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in science, industry and agriculture, namely, compounds and reagents for scientific or research use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific or research use; diagnostic preparations for scientific or research use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; diagnostic preparations for scientific or research use for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens | ACTIVE | — |
| 005 | Chemicals used for medical purposes, namely, compounds and reagents for medical use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; single-use laboratory articles and arrays consisting of chemical kits comprising compounds and reagents for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; diagnostic preparations for medical use for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; diagnostic preparations for medical use for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ISIS Pharmaceuticals, Inc.
- Other trademarks owned by ISIS Pharmaceuticals, Inc.
- Other trademarks owned by IBIS BIOSCIENCES, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named IBIS BIOSCIENCES
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 28, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 28, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 3, 2009 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 2, 2009 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 2, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 28, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 28, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 11, 2009 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 9, 2009 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 9, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 17, 2008 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 1, 2008 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 1, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 25, 2008 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 25, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 2, 2008 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 27, 2008 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 27, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 18, 2007 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 28, 2007 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 28, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 29, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 6, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 14, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 12, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 8, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 8, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 8, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 8, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 4, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 4, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2007 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2006 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 6, 2006 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 7, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 11, 2006 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Mar 29, 2006 | NWAP | NEW APPLICATION ENTERED | — |